Open Access

Suppression of circulating AP001429.1 long non‑coding RNA in obese patients with breast cancer

  • Authors:
    • Hani Choudhry
    • Mohammed A. Hassan
    • Abdulrahman L. Al‑Malki
    • Kaltoom A. Al‑Sakkaf
  • View Affiliations

  • Published online on: May 3, 2021     https://doi.org/10.3892/ol.2021.12769
  • Article Number: 508
  • Copyright: © Choudhry et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Long non‑coding RNAs (lncRNAs), a type of cellular RNA, play a critical regulatory role in several physiological developments and pathological processes, such as tumorigenesis and tumor progression. Obesity is a risk factor for a number of serious health conditions, including breast cancer (BC). However, the underlying mechanisms behind the association between obesity and increased BC incidence and mortality remain unclear. Several studies have reported changes in lncRNA expression due to obesity and BC, independently encouraging further investigation of the relationship between the two in connection with lncRNAs. The present study was designed to first screen for the expression of 29 selected lncRNAs that showed a link to cancer or obesity in the blood of a selected cohort of 6 obese and 6 non‑obese patients with BC. The expression levels of significantly expressed lncRNAs, AP001429.1, PCAT6, P5549, P19461 and P3134, were further investigated in a larger cohort of 69 patients with BC (36 obese and 33 non‑obese), using reverse transcription‑quantitative polymerase chain reaction. Results showed not only that AP001429.1 remained significantly downregulated in the larger cohort (P=0.002), but also that it was associated with several clinicopathological characteristics, such as negative HER2 status, negative E‑cadherin expression, negative vascular invasion, negative margin invasion and LCIS. These findings suggest that obesity may have a role in inhibiting AP001429.1 expression, which may serve as a novel potential biomarker and therapeutic target for BC.

Related Articles

Journal Cover

July-2021
Volume 22 Issue 1

Print ISSN: 1792-1074
Online ISSN:1792-1082

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Choudhry H, Hassan MA, Al‑Malki AL and Al‑Sakkaf KA: Suppression of circulating <em>AP001429.1</em> long non‑coding RNA in obese patients with breast cancer. Oncol Lett 22: 508, 2021
APA
Choudhry, H., Hassan, M.A., Al‑Malki, A.L., & Al‑Sakkaf, K.A. (2021). Suppression of circulating <em>AP001429.1</em> long non‑coding RNA in obese patients with breast cancer. Oncology Letters, 22, 508. https://doi.org/10.3892/ol.2021.12769
MLA
Choudhry, H., Hassan, M. A., Al‑Malki, A. L., Al‑Sakkaf, K. A."Suppression of circulating <em>AP001429.1</em> long non‑coding RNA in obese patients with breast cancer". Oncology Letters 22.1 (2021): 508.
Chicago
Choudhry, H., Hassan, M. A., Al‑Malki, A. L., Al‑Sakkaf, K. A."Suppression of circulating <em>AP001429.1</em> long non‑coding RNA in obese patients with breast cancer". Oncology Letters 22, no. 1 (2021): 508. https://doi.org/10.3892/ol.2021.12769